background aat deficiency probably individuals affected clinical impairment targeted detection tool increase recognition methods prospectively submitted aat serum levels determination phenotyping doubtful genotyping patients early onset emphysema emphysema absence recognized risk pneumothorax path p antineutrophil cytoplasm antibodies anca positive vasculitis path v cervical artery dissection path periodic pas positive bodies liver cell unexplained abnormal transaminase level path l index cases ic ii subjects alpha1globulin path e close relatives patients aat deficiency path r non index cases nic determined compared gender age aat serum levels values ratio aat deficiency subjects identified subjects examined receiver operating characteristic roc curve plotted best threshold aat serum levels results individuals examined NUMBER aat deficiency identified NUMBER ic NUMBER nic ratio resulted NUMBER serum level NUMBER able identify aat deficiency specificity NUMBER sensitivity NUMBER ic showed male prevalence p0005 advanced age p002 lower aat serum levels p0008 conclusions protocol effective detect aat deficiency selected population NUMBER nephelometric method reliable aat serum level selecting submit phenotype genotype compared nic ic older male lower aat serum levels alpha1 antitrypsin recognized acid schiff low serum eighty cut identified examined identified examined mg dl mg dl subjects patients